[ET Net News Agency, 22 May 2019] Sino Biopharmaceutical Limited (01177) said its
profit attributable to owners of the parent was RMB856.7 million for the three months
ended 31 March 2019, a year-on-year increase of 11.1%. The earnings per share were RMB6.8
cents. A quarterly dividend of HK2 cents will be distributed.
The revenue was RMB6.21 billion, a year-on-year increase of 33.43%. The gross profit was
RMB5 billion, a year-on-year increase of 34.62%. (RC)